Finding a health plan on the Medicare website could be troublesome for some seniors.
Finding a health plan on the Medicare website could be troublesome for some seniors. According to Gina Upchurch, executive director of Senior PharmAssist, a nonprofit group in North Carolina, a plan finder tool on the government’s website is showing higher prices for a prescription filled every 2 or 3 months compared with the same drug bought every month under 2014 drug policies. “You’re buying less and paying more,” she said.
Prescriptions such as eye drops, creams, or inhalers can last for more than a month, yet some insurers cap discounting for prescription drugs other than for 30-day regimens. Dr Upchurch found one plan that charged a beneficiary with a monthly prescription for eye drops $7 a month during the initial coverage period to get the drug, while another person who has a prescription for the drops to be filled every 60 days would pay $51. Another 2 plans she compared charge $40 or $45 for 3 vials of insulin every month in the initial coverage period, and $575 every 2 months.
Fred Riccardi, director of client services at the Medicare Rights Center, says elderly patients should call their insurers to seek out alternative plan options that might reduce costs, such as ordering through the mail order pharmacy. However, Dr Upchurch argues, “People shouldn’t have to run around to different pharmacies” and that “It would be better if Medicare required plans to cover whatever supply a provider prescribes.”
Elderly beneficiaries may encounter additional barriers to affordable healthcare due to their lack of access to the Internet. A study released in September by the Pew Internet & American Life Project found that a disproportionate amount of older Americans do not use the Internet. Kathryn Zickuhr, who wrote the Pew study, found 49% of non-Internet users are older than 65 years.
Around the Web
Strange Pricing Details Can Bedevil Medicare Beneficiaries [Kaiser Health News]
Gap Between Those Who Use Internet and Those Who Don’t is Widening
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More